JPS6287241A - Oil droplet-in-water type emulsion composition - Google Patents
Oil droplet-in-water type emulsion compositionInfo
- Publication number
- JPS6287241A JPS6287241A JP60226407A JP22640785A JPS6287241A JP S6287241 A JPS6287241 A JP S6287241A JP 60226407 A JP60226407 A JP 60226407A JP 22640785 A JP22640785 A JP 22640785A JP S6287241 A JPS6287241 A JP S6287241A
- Authority
- JP
- Japan
- Prior art keywords
- emulsion composition
- hlb
- nonionic surfactant
- specified
- water type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Cosmetics (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Colloid Chemistry (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、生薬を従来になく多量に配合した乳化組成物
に関するものであり、更に詳しくは長期保存後において
も使用性に優れる生薬配合乳化組成・物に関する。[Detailed Description of the Invention] [Field of Industrial Application] The present invention relates to an emulsion composition containing an unprecedentedly large amount of crude drugs, and more specifically, an emulsion containing crude drugs that has excellent usability even after long-term storage. Concerning composition/things.
近年、各種生薬を配合した乳化組成物の開発が盛んに行
なわれるようになってきている。これは。In recent years, development of emulsified compositions containing various crude drugs has been actively conducted. this is.
自然で安全性の高い化粧料を、消費者に提供し、また生
薬独特の自然回復力を助ける作用を利用して、健康な皮
膚を保とうとする消費者の健康意識に応えようとするも
のである。The aim is to provide consumers with natural and highly safe cosmetics, and to respond to the health consciousness of consumers who want to maintain healthy skin by utilizing the unique natural recovery power of herbal medicines. be.
しかしながら、一般に、生薬には、乳化系を不安定にす
る成分が含まれており、これを多量に配合した乳化化粧
料は、長期の保存安定性に欠け。However, crude drugs generally contain ingredients that make the emulsion system unstable, and emulsified cosmetics containing large amounts of these ingredients lack long-term storage stability.
またその使用性に問題を生じるため、市販されている多
くの生薬配合乳化粧料は、生薬の配合量を少なくシ、製
品の保存安定性を図っている。このような生薬配合乳化
粧料の代表的なものとしてはアロエ配合化粧料が知られ
ている。In addition, because of the problem of usability, many commercially available milk cosmetics containing crude drugs contain a small amount of crude drugs in order to improve the storage stability of the product. Cosmetics containing aloe vera are known as a typical example of such milk cosmetics containing crude drugs.
アロエ植物には、■創傷治療作用■細胞賦活作用■保温
作用等の顕著な効能がある。したがって、その抽出束を
化粧料に配合すれば、肌荒れ。Aloe plants have remarkable efficacy such as ■ wound healing effect ■ cell activation effect ■ heat retention effect. Therefore, if you add the extract to cosmetics, it will prevent rough skin.
ひび、あかぎれ等に対し顕著な薬効が期待できるもので
ある。しかし市販されているアロエ配合化粧料は、たか
だか0.1%程度の粉末又は固型の抽出束を配合してい
るに過ぎなく、アロエの効能を充分に発揮するものでは
なかった。上述のアロエの薬効を充分発揮させるために
は、原草中の濃度に近い濃度となるような多量の抽出末
を化粧料中に配合しなければならない。具体的には化粧
料中に抽出末として少なくとも0.5%以上配合する必
要がある。It is expected to have remarkable medicinal effects on cracks, chapped skin, etc. However, commercially available aloe-containing cosmetics contain at most about 0.1% of powdered or solid extract bundles, and do not fully exhibit the efficacy of aloe. In order to fully exhibit the above-mentioned medicinal effects of aloe, it is necessary to incorporate a large amount of extracted powder into cosmetics so that the concentration is close to that in the original plant. Specifically, it is necessary to incorporate at least 0.5% of extract powder into cosmetics.
しかしながら、例えば、アロエ抽出末を0.5%以上の
濃度となるように、化粧クリームに配合した場合、アロ
エ中に含まれる水溶性有機酸塩、水溶性無機塩類等の影
響により乳化系が極めて不安定となり、得られる化粧料
は長期保存後の使用性が悪くなるため、その商品価値が
低下するという問題を生じる。However, for example, when aloe extract powder is blended into a cosmetic cream at a concentration of 0.5% or more, the emulsification system becomes extremely difficult due to the effects of water-soluble organic salts, water-soluble inorganic salts, etc. contained in aloe. This causes instability, and the usability of the resulting cosmetic after long-term storage deteriorates, resulting in a problem of reduced commercial value.
本発明の目的は、アロエ等のユリ科多肉植物生薬又はキ
ュウリ、ヘチマ、カラスウリ等のウリ科植物生薬を従来
になく多量に配合でき、かつ長期間保存しても安定で使
用性の優れた氷中油滴型乳化剤組成物を提供することに
ある。The purpose of the present invention is to create an ice cream that can contain an unprecedented amount of herbal medicines from succulent plants of the Liliaceae family, such as aloe, or herbal medicines from plants of the Cucurbitaceae family, such as cucumber, loofah, and gourd, which is stable even when stored for a long period of time, and has excellent usability. An object of the present invention is to provide a medium oil droplet type emulsifier composition.
本発明によれば、アロエ等のユリ科多肉植物生薬又は、
キュウリ、ヘチマ、カラスウリ等のウリ科植物生薬を含
む氷中油滴型乳化組成物中に、乳化剤として、HLB2
.O〜5.0の親油型非イオン界面活性剤及びHLB1
4〜18のポリエチレングリコールステアリン酸エステ
ルを含有させるとともに、乳化助剤として高級アルコー
ルを含有させたことを特徴とする氷中油滴型乳化組成物
が提供される。According to the present invention, herbal medicines from Liliaceae succulent plants such as aloe or
In an oil-in-ice emulsion composition containing herbal medicines from Cucurbitaceae plants such as cucumber, loofah, and gourd, HLB2 is added as an emulsifier.
.. O~5.0 lipophilic nonionic surfactant and HLB1
An oil-in-ice emulsion composition is provided, which contains polyethylene glycol stearate 4 to 18 and a higher alcohol as an emulsification aid.
すなわち、本発明は、上記生薬を多量に配合しても、長
期間の保存に安定で使用性に優れた氷中油滴型乳化組成
物を得るために、乳化剤として、上記した特定のHLB
を有する親油型非イオン界面活性剤とポリエチレングリ
コールステアリン酸エステルを用いると共に、乳化助剤
として、高級アルコールを用いたものである。That is, the present invention uses the above-described specific HLB as an emulsifier in order to obtain an oil-in-ice emulsion composition that is stable for long-term storage and has excellent usability even when a large amount of the above-mentioned herbal medicine is blended.
In addition to using a lipophilic nonionic surfactant having the following formula and polyethylene glycol stearate, a higher alcohol is used as an emulsification aid.
以下1本発明を更に詳細に説明する。The present invention will be explained in more detail below.
本発明において用いる生薬は、アロエ等のユリ科多肉植
物、又はキュウリ、ヘチマ等のウリ科植物の葉、根、茎
、花実を適当な公知手段で抽出したものである。生薬の
形態は抽出液もしくはそれらを乾燥した抽出末のいずれ
かである。乾燥抽出末を化粧料に配合する場合は、その
ままで、抽出液を配合する場合は固形分含量に換算した
量が配合される。この配合量は、乳化組成物に対し、0
.5〜5重量%(好ましくは0.5〜2重量%)とする
のが適当である。The herbal medicine used in the present invention is obtained by extracting leaves, roots, stems, and fruits of succulent plants of the Liliaceae family, such as aloe, or plants of the Cucurbitaceae family, such as cucumbers and loofahs, by suitable known means. The form of crude drugs is either extracts or dried extract powders. When the dry extract powder is blended into cosmetics, it is used as is, and when the extract liquid is blended, the amount converted to the solid content is blended. This blending amount is 0 for the emulsified composition.
.. A suitable amount is 5 to 5% by weight (preferably 0.5 to 2% by weight).
本発明で用いるHLB2.0〜5.0の親油型非イオン
界面活性剤としては、例えば、グリセリルモノステアレ
ート、グリセリルイソステアレート、グリセリルモノミ
リステイト、グリセリルモノオレート、ソルビタンモノ
ステアレート、ソルビタンセスキステアレート、ソルビ
タンモノオレエート、ソルビタンセスキオレエート、ソ
ルビタンモノイソステアレート、プロピレングリコール
モノステアレート等が挙げられるが、クリーム等のよう
な粘調度の高い乳化物を得るには、常温で固体状のもの
を用いることが適当である。また、該親油型非イオン界
面活性剤は、乳化組成物中に0.5〜2.5重量%程度
配合することが好ましい。配合量が0.5重量%未満で
あると乳化剤系が親水性になりすぎて安定な氷中油滴型
乳化物を得ることが困錐となり、また2、5重量%を超
えると親油性になりすぎて安定な氷中油滴型乳化物は得
難くなる。更に1本発明においては、乳化剤として、前
記親油型非イオン界面剤と共に、HLB14〜18のポ
リエチレングリコールステアリン酸エステルを用いる。Examples of lipophilic nonionic surfactants with HLB 2.0 to 5.0 used in the present invention include glyceryl monostearate, glyceryl isostearate, glyceryl monomyristate, glyceryl monooleate, sorbitan monostearate, and sorbitan. Examples include sesquistearate, sorbitan monooleate, sorbitan sesquioleate, sorbitan monoisostearate, propylene glycol monostearate, etc., but in order to obtain emulsions with high viscosity such as cream etc. It is appropriate to use a Moreover, it is preferable that the lipophilic nonionic surfactant is blended in the emulsion composition in an amount of about 0.5 to 2.5% by weight. If the amount is less than 0.5% by weight, the emulsifier system becomes too hydrophilic, making it difficult to obtain a stable oil-in-ice emulsion, and if it exceeds 2.5% by weight, it becomes lipophilic. This makes it difficult to obtain a stable oil-in-ice emulsion. Furthermore, in the present invention, polyethylene glycol stearate having an HLB of 14 to 18 is used as an emulsifier together with the lipophilic nonionic surfactant.
HLBが14未満であると乳化剤系が親油性のものにな
りすぎるので、好ましくなく、またHLBが18を超え
ると余りに親水性のものになってしまうので適当でない
。If the HLB is less than 14, the emulsifier system becomes too lipophilic, which is undesirable, and if the HLB exceeds 18, it becomes too hydrophilic, which is not suitable.
また、その配合量は、乳化組成物中に0.8〜3.0重
量%とするのが好ましく、0.8重量%未満であると乳
化剤系が親油性になりすぎ、又3.0重量%を超えると
親水性になりすぎて安定な氷中油滴型乳化物が得られな
い。In addition, the amount incorporated is preferably 0.8 to 3.0% by weight in the emulsified composition; if it is less than 0.8% by weight, the emulsifier system becomes too lipophilic; %, it becomes too hydrophilic and a stable oil-in-ice emulsion cannot be obtained.
また、乳化助剤として用いる高級アルコールとしては、
ラウリルアルコール、セタノール、ステアリルアルコー
ル、ベヘニルアルコール、ヘキシルデカノール、オクチ
ルドデカノール等が挙げられるが、安定性を向上させる
ものとしては、常温で固体状のものが好ましく、またそ
の配合量は、乳化組成物中、0.5〜5.0重量%の範
囲とするのが適当である。In addition, higher alcohols used as emulsification aids include:
Examples include lauryl alcohol, cetanol, stearyl alcohol, behenyl alcohol, hexyldecanol, octyldodecanol, etc., but those that are solid at room temperature are preferable as substances that improve stability, and the blending amount thereof is determined in the emulsified composition. A suitable range is 0.5 to 5.0% by weight.
本発明においては、乳化剤として、)lLB2.o〜5
.0の親油型非イオン界面活性剤及び1(LB14〜工
8のポリエチレングリコールステアリン酸エステルを、
乳化助剤として、高級アルコールを用いたことにより、
前記生薬を多量に配合でき、しかも長期保存後の使用性
においても優れる氷中油滴型乳化組成を得ることができ
る、
尚、乳化剤として、従来よく知られた乳化剤である脂肪
酸ナトリウム塩、脂肪酸カリウム塩、脂肪酸トリエタノ
ールアミン塩、アルキル硫酸塩、アルキルリン酸塩、ポ
リオキシエチレンアルキルリン酸塩等の7ニオン界面活
性剤を用いた場合には、生薬中に含まれる水溶性無機塩
等の影響により該アニオン界面活性剤が複分解を起こす
ため。In the present invention, as an emulsifier, )lLB2. o~5
.. 0 lipophilic nonionic surfactant and 1 (polyethylene glycol stearate ester of LB14-8),
By using higher alcohol as an emulsification aid,
It is possible to obtain an oil-in-ice emulsion composition in which a large amount of the crude drug can be blended and which is also excellent in usability after long-term storage.As the emulsifier, conventionally well-known emulsifiers such as fatty acid sodium salts and fatty acid potassium salts can be used. When using 7-ion surfactants such as fatty acid triethanolamine salts, alkyl sulfates, alkyl phosphates, and polyoxyethylene alkyl phosphates, due to the influence of water-soluble inorganic salts contained in crude drugs, This is because the anionic surfactant causes double decomposition.
長期の使用期間において、充分に安定な乳化物を得るこ
とができない。It is not possible to obtain a sufficiently stable emulsion for a long period of use.
また、塩化ステアリルトリメチルアンモニウム、塩化セ
チルトリメチルアンモニウム、塩化ラウリルトリメチル
アンモニウム等のカチオン界面活性剤は、皮膚に対する
安全性の面から、外用剤、皮膚化粧料に用いることは困
難である。Furthermore, it is difficult to use cationic surfactants such as stearyltrimethylammonium chloride, cetyltrimethylammonium chloride, and lauryltrimethylammonium chloride in external preparations and skin cosmetics from the viewpoint of safety for the skin.
また、更に乳化安定剤として、ポリアクリル酸ナトリウ
ム、カルボキシメチルセルロース、カルボキシビニルポ
リマー、アクリル酸メチルメタクリルコポリマー、ヒド
ロキシエチルセルロース等の高分子増粘剤を用いると、
生薬中の水溶性無機塩等の影響により低粘化を起こすた
め、本発明の目的を達成することができない。Furthermore, when a polymer thickener such as sodium polyacrylate, carboxymethylcellulose, carboxyvinyl polymer, methylmethacrylic acrylate copolymer, or hydroxyethylcellulose is used as an emulsion stabilizer,
The object of the present invention cannot be achieved because viscosity decreases due to the influence of water-soluble inorganic salts in the herbal medicine.
また、本発明においては、乳化組成物を形成する油相成
分として、所望によりミツロウ、鯨ロウ等のロウ類:流
動パラフィン、ワセリン、セレシン、マイクロクリスタ
リンワックス、スクワラン、プリスタン等の炭化水素二
ミリスチン酸、ステアリン酸、ベヘニン酸等の高級脂肪
酸:ミリスチン酸イソプロピル、パルミチン酸イソプロ
ピル、ミリスチン酸ミリスチル、ミリスチン酸オクチル
ドデシル等のエステル類を泪いることができる。In the present invention, as an oil phase component forming the emulsified composition, waxes such as beeswax and spermaceti; hydrocarbon dimyristic acid such as liquid paraffin, petrolatum, ceresin, microcrystalline wax, squalane, and pristane; , higher fatty acids such as stearic acid and behenic acid; and esters such as isopropyl myristate, isopropyl palmitate, myristyl myristate, and octyldodecyl myristate.
また、本発明においては、その他特殊成分として酸化防
止剤、ビタミン類、紫外線吸収剤、保湿剤、キレート剤
、防腐剤、殺菌剤等を適宜加えることもできる。Further, in the present invention, other special ingredients such as antioxidants, vitamins, ultraviolet absorbers, humectants, chelating agents, preservatives, bactericidal agents, etc. can also be added as appropriate.
〔実施例〕 本発明を、実施例により更に詳細に説明する。〔Example〕 The present invention will be explained in more detail with reference to Examples.
実施例1〜3、比較例1〜9 く乳化組成物の調製方法〉 表−1に示されるような水相部を60℃に保つ。Examples 1-3, Comparative Examples 1-9 Method for preparing emulsified composition> The aqueous phase as shown in Table 1 is maintained at 60°C.
この水相部をホモミキサーで攪拌しながらあらかじめ7
0°Cで混合しておいた表−1に示されるような油相部
を加え、均一に乳化し、乳化後パドルミキサーで攪拌し
ながら室温まで冷却する。なお、使用したアロエ抽出末
は、原草を搾汁した後活性炭で精製し、次に減圧乾燥し
て得られたもので原草100部から1部得られたもので
ある。従って、本生薬を組成中゛に1部配合すれば、組
成中に原草として100%配合したことになる。また、
香料は乳化後約50℃で添加した。While stirring this aqueous phase with a homomixer,
Add the oil phase as shown in Table 1, which has been mixed at 0°C, and emulsify uniformly. After emulsification, cool to room temperature while stirring with a paddle mixer. The aloe extract powder used was obtained by squeezing the raw grass, purifying it with activated carbon, and then drying it under reduced pressure, and 1 part was obtained from 100 parts of the raw grass. Therefore, if one part of this herbal medicine is blended into the composition, it means that 100% of the herbal medicine is blended into the composition as the original herb. Also,
The fragrance was added at about 50°C after emulsification.
〈乳化組成物の試験方法〉
(1)乳化組成物の保存条件及び保存期間通常の室温で
1年保存
(2)評価項目
■クリーム状組成物
外観(きめ、つや)、粘稠度、指への取り易さ、皮膚の
上での伸び易さ、皮膚への溶は込み易さ、分離の有無
■乳液状組成物
外観(きめ、つや)、粘稠度、流動性、容器からの出し
易さ、皮膚の上での伸び易さ、皮膚への溶は込み易さ、
分離の有無
(3)評価者
化粧品の官能検査に熟達している検査者10名(4)判
定基準
0・・・長期保存後の使用性に優れ、商品価値が優れて
いる。<Test method for emulsified compositions> (1) Storage conditions and storage period of emulsified compositions Stored for 1 year at normal room temperature (2) Evaluation items ■Cream composition appearance (texture, gloss), consistency, stickiness to fingers Ease of removal, ease of spreading on the skin, ease of dissolving into the skin, presence or absence of separation ■ Emulsion composition appearance (texture, gloss), viscosity, fluidity, ease of removal from the container ease of spreading on the skin, ease of dissolving into the skin,
Presence or absence of separation (3) Evaluators: 10 testers who are skilled in sensory testing of cosmetics (4) Judgment criteria: 0: Excellent usability after long-term storage and excellent commercial value.
Δ・・・長期保存後の使用性に劣り、商品価値が低下す
る。Δ: Usability after long-term storage is poor, and commercial value is reduced.
X・・・長期保存後の使用性が著しく劣り、商品価値が
ない。X: Usability after long-term storage is significantly poor, and there is no commercial value.
試験結果を表−Iに示す。The test results are shown in Table-I.
表−■から、アロエ抽出末が1%(原車として100%
)と多量に配合されると、アニオン界面活性剤及び/又
は非イオン界面活性剤及び/又は高級アルコールの組合
せでは、長期保存後の使用性に優れた水中油滴型乳化組
成物を得ることはできない(比較例1〜7)が、HLB
2.0〜5.0の親油型非イオン界面活性剤及びHLB
14〜18のポリエチレングリコールステアリン酸エス
テルからなる乳化剤と高級アルコールからなる乳化助剤
を組合せた本発明においては、長期保存後の使用性に優
れた氷中油滴型乳化組成物が得られることが判る。From Table - ■, aloe extract powder is 1% (100% as original car)
), it is difficult to obtain an oil-in-water emulsion composition with excellent usability even after long-term storage with the combination of anionic surfactants and/or nonionic surfactants and/or higher alcohols. Not possible (Comparative Examples 1 to 7), but HLB
2.0-5.0 lipophilic nonionic surfactant and HLB
It can be seen that in the present invention, which combines an emulsifier made of polyethylene glycol stearate 14 to 18 and an emulsification aid made of a higher alcohol, an oil-in-ice emulsion composition with excellent usability after long-term storage can be obtained. .
実施例4〜7
実施例1のアロエ抽出末を下記の生薬に代えた以外は実
施例1と同様の試験を行った。結果を表−nに示す。い
ずれの配合例も、長期保存後の使用性に優れた乳化組成
物であることを表わしている。Examples 4 to 7 The same tests as in Example 1 were conducted except that the aloe extract powder in Example 1 was replaced with the following herbal medicine. The results are shown in Table n. All formulation examples demonstrate that the emulsion composition is excellent in usability after long-term storage.
表−■
〔発明の効果〕
本発明の生薬配合水中油滴型乳化組成物は、乳化剤とし
てHLB2.0〜5.0の親油型非イオン界面活性剤及
びHLB14〜18のポリエチレングリコールステアリ
ン酸エステルを、乳化助剤として高級アルコールを含有
させたことにより、前記生薬が多量に配合されているに
もかかわらず、長期保存後においても、その使用性に優
れ、商品価値の向上したものである。Table - ■ [Effect of the invention] The oil-in-water emulsion composition containing crude drugs of the present invention contains a lipophilic nonionic surfactant with an HLB of 2.0 to 5.0 and a polyethylene glycol stearate with an HLB of 14 to 18 as an emulsifier. By containing a higher alcohol as an emulsification aid, the product has excellent usability and improved commercial value even after long-term storage, even though it contains a large amount of the crude drug.
Claims (1)
ヘチマ、カラスウリ等のウリ科植物生薬を含む水中油滴
型乳化組成物中に、乳化剤として、HLB2.0〜5.
0の親油型非イオン界面活性剤及びHLB14〜18の
ポリエチレングリコールステアリン酸エステルを含有さ
せるとともに、乳化助剤として高級アルコールを含有さ
せたことを特徴とする水中油滴型乳化組成物。(1) Liliaceous succulent herbal medicine such as aloe or cucumber,
In an oil-in-water emulsion composition containing herbal medicines from Cucurbitaceae plants such as loofah and gourd, an emulsifier with an HLB of 2.0 to 5.
1. An oil-in-water emulsion composition characterized in that it contains a lipophilic nonionic surfactant of 0 and a polyethylene glycol stearate of HLB 14 to 18, as well as a higher alcohol as an emulsification aid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60226407A JPS6287241A (en) | 1985-10-11 | 1985-10-11 | Oil droplet-in-water type emulsion composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60226407A JPS6287241A (en) | 1985-10-11 | 1985-10-11 | Oil droplet-in-water type emulsion composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6287241A true JPS6287241A (en) | 1987-04-21 |
JPH0576336B2 JPH0576336B2 (en) | 1993-10-22 |
Family
ID=16844633
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP60226407A Granted JPS6287241A (en) | 1985-10-11 | 1985-10-11 | Oil droplet-in-water type emulsion composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6287241A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992015563A1 (en) * | 1991-02-28 | 1992-09-17 | Parfums Christian Dior | Use of cucurbitin for the preparation of a cosmetic or pharmaceutical, particularly dermatological, antiallergenic composition and method involving application thereof |
US5653997A (en) * | 1991-02-28 | 1997-08-05 | Parfums Christian Dior | Antiallergic cosmetic or pharmaceutical composition |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5777610A (en) * | 1980-10-31 | 1982-05-15 | Rowaale Keshohin Kk | Agent for skin application |
JPS5913716A (en) * | 1982-07-16 | 1984-01-24 | Lion Corp | Composition for external use |
JPS6087207A (en) * | 1983-10-19 | 1985-05-16 | Iwasekenjirou Shoten:Kk | Deramatic drug for external use containing extract of aloe and its preparation |
JPS61289010A (en) * | 1985-06-15 | 1986-12-19 | Nonogawa Shoji:Kk | Cosmetic |
-
1985
- 1985-10-11 JP JP60226407A patent/JPS6287241A/en active Granted
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5777610A (en) * | 1980-10-31 | 1982-05-15 | Rowaale Keshohin Kk | Agent for skin application |
JPS5913716A (en) * | 1982-07-16 | 1984-01-24 | Lion Corp | Composition for external use |
JPS6087207A (en) * | 1983-10-19 | 1985-05-16 | Iwasekenjirou Shoten:Kk | Deramatic drug for external use containing extract of aloe and its preparation |
JPS61289010A (en) * | 1985-06-15 | 1986-12-19 | Nonogawa Shoji:Kk | Cosmetic |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992015563A1 (en) * | 1991-02-28 | 1992-09-17 | Parfums Christian Dior | Use of cucurbitin for the preparation of a cosmetic or pharmaceutical, particularly dermatological, antiallergenic composition and method involving application thereof |
US5653997A (en) * | 1991-02-28 | 1997-08-05 | Parfums Christian Dior | Antiallergic cosmetic or pharmaceutical composition |
US5696273A (en) * | 1991-02-28 | 1997-12-09 | Parfums Christian Dior | Method for synthesizing cucurbitine |
US5714164A (en) * | 1991-02-28 | 1998-02-03 | Parfums Christian Dior | Method for treatment of allergic disorders and cosmetic compositions using cucurbitine |
Also Published As
Publication number | Publication date |
---|---|
JPH0576336B2 (en) | 1993-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6010418B2 (en) | Emulsified composition | |
JPS59108716A (en) | Antiacne composition | |
WO2017131217A1 (en) | RIPPLE-PHASE-CONTAINING COMPOSITION, α-GEL FORMATION COMPOSITION, EXTERNAL SKIN CARE COMPOSITION USING α-GEL FORMATION COMPOSITION, AND α-GEL COMPOSITION USING α-GEL FORMATION COMPOSITION | |
KR20150116655A (en) | Cosmetic composition stabilizing insoluble functional ingredient | |
JP5753466B2 (en) | Liquid cosmetics | |
KR20190036341A (en) | Cosmetic Composition for Reducing Stickiness and Improving Transparency of Emulsion Formulation | |
JPH0751491B2 (en) | Emulsified cosmetics containing crude drugs | |
JPS58183611A (en) | Cosmetic of polyphase emulsification type | |
JP2017081895A (en) | Oil-in-water type emulsion composition | |
US5567419A (en) | Stabilized cosmetic compositions containing monoacyl phosphatide and a saponin | |
EP0375082B1 (en) | Cosmetic composition | |
WO2015064681A1 (en) | Composition for external use | |
JPS6287241A (en) | Oil droplet-in-water type emulsion composition | |
JP4045160B2 (en) | Skin preparation | |
JP3978611B2 (en) | Cosmetic composition | |
JP2556730B2 (en) | Skin cosmetics | |
JP3441387B2 (en) | Moisturizer, skin cosmetics and bath additives | |
JP3597520B2 (en) | External preparation for skin | |
KR100888752B1 (en) | External dermal agent | |
WO2020245569A1 (en) | Skin treatment composition | |
JPH0987128A (en) | Capsule having sebum absorptivity and dermal preparation for external use containing the same capsule | |
JPH02169507A (en) | Cosmetic | |
JP3349544B2 (en) | Skin cosmetics | |
WO2023042911A1 (en) | Anti-armpit-odor composition | |
JP3492754B2 (en) | Bath composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |